BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Highlighting Innovation in Breast and Ovarian Cancer on International Women’s Day

  Currently, women with breast and ovarian cancers have limited treatment options. Anixa Biosciences, ImmunoGen and IMV are working to change that.

  March 8, 2022

   · 

  5 min read

   · 

  Rosemary Scott
• 

  Business

  Novartis Taps into Voyager’s TRACER Platform in Deal Valued at $1.7B

  Voyager has partnered with Novartis for the latter to use the gene therapy company’s capsid discovery platform to create new treatments for three undisclosed CNS targets.

  March 8, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Genetown

  Moderna Global Strategy Sets Sights on 15 Priority Pathogens

  On Monday, Moderna announced its initiative that promises to advance those 15 programs into the clinic by 2025.

  March 8, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Creyon Bio is Creating Precision Medicines for Diseases Common and Rare

  Creyon Bio, a drug development company, has launched with more than $40 million in seed and Series A financing led by DCVC Bio and Lux Capital.

  March 8, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  COVID-19 Update: Fears of a Ukraine Outbreak and Brain Changes in Long-COVID

  Potential outbreaks in Ukraine, genetic variants cause worsened symptoms, new long-term effects discovered and Florida political representatives advise against vaccines for kids.

  March 8, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Valneva Sets Precedent with Strong Phase III Chikungunya Vaccine Results

  The single-shot chikungunya vaccine was shown to be safe and effective against mosquito-transmitted chikungunya disease in a published analysis of Phase III results.

  March 8, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Business

  Going All In on mRNA, Sanofi Breaks Ground on New Vaccine Site

  Sanofi will more than $1 billion to build out its mRNA facilities and programs over the next several years. The site is expected to become operational in 2025.

  March 8, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  10 Intriguing positions in Biopharma

  From research to sales and marketing, the pharma industry has a wide range of employment opportunities to accommodate those looking for a chance to work in the field.

  March 8, 2022

   · 

  5 min read

   · 

  Brandi Marcene
• 

  Policy

  J&J Faces Scrutiny over Revelation of Involvement in Controversial Experiment

  Court documents outline J&J’s involvement in a dermatology experiment 50 years ago on incarcerated individuals, most of whom were African American.

  March 8, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  COVID-19 Changed the Biopharma Industry - and There’s No Going Back

  From artificial intelligence breakthroughs to at-home genetic testing, here are some ways COVID-19 has changed the biopharma industry and what we may see in the near future.

  March 8, 2022

   · 

  6 min read

   · 

  Hannah Chudleigh